Election 2005 and Health Issues

This coming week is election time here in the US. We'll all go to the polls and vote for our candidate of choice. Democracy in action.



I have a few questions for you to consider:



Where do your candidates stand on health care issues? Do you know? There are bills in the US legistature to both increase and cut funding for health and cancer issues - would your slate of candidates vote for an issue or against? What about health care deductions, flexible spending accounts for health costs and the like? Do they support the Family Leave and Protection Act in case you or a loved one must take extended leave due to illness?



I am not advocating parties or movements - I'd just like people in situations similar to mine and my readers to ask their candidates some questions on issues that might dramatically affect them.



Once you know, then vote your choice - you'll have made an informed decision and that's what sites like this one advocate every day, whether it's at the polls or in the doctor's office.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap